This site is intended for healthcare professionals

SGLT2 Inhibitors in Extra-Glycaemic Indications: Use in People with Renal Impairment
This GPnotebook Shortcut provides dose recommendations for sodium–glucose co-transporter 2 (SGLT2) inhibitors according to renal impairment, specifically focusing on the use of these agents in indications other than the treatment of hyperglycaemia in type 2 diabetes.